Literature DB >> 6772538

Structure of the Ss blood group antigens, II: a methionine/threonine polymorphism within the N-terminal sequence of the Ss glycoprotein.

W Dahr, K Beyreuther, H Steinbach, W Gielen, J Krüger.   

Abstract

The N-terminal amino acid sequence (residues 1--35) of the Ss sialoglycoprotein (or glycophorin B) from human erythrocyte membranes of defined Ss blood group activity was determined by manual sequencing methods, using N-terminal tryptic or chymotryptic glycopeptides and various secondary peptides. The proposed structure differs considerably from that suggested on the basis of work with glucopeptides of unknown Ss blood group activity (Furthmayr, Nature 271, 519--523, 1978). Only one difference between glycopeptides from Ss and ss erythrocytes was found, i.e. a methionine/threonine polymorphism at position 29. On the basis of previous work (Dahr et al., Hoppe-Seyler's Z. Physiol. Chem. 361, 145--152, 1980), it is concluded that this amino acid heterogeneity represents the Ss polymorphism rather than the UX or UZ polymorphisms, which are in strong genetic linkage disequilibrium with the Ss antigens. A part of the sequence (residues 9--30) of the major (MN) red cell membrane sialoglycoprotein (glycophorin A) was re-investigated and revised at positions 11 and 17. As judged from the present data, the first 26 residues of the Ss and the blood group N-specific MN glycoprotein are identical. The sequence 27--35 of the Ss glycoprotein shows a homology with the residues 56--64 and 59--67 of the MN glycoprotein. Data on the partial N-terminal sequence of glycopeptides from a third erythrocyte membrane sialoglycoprotein (component D or glycophorin C) indicate that its structure is different from those of the two other glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772538     DOI: 10.1515/bchm2.1980.361.1.895

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  12 in total

1.  Characterization of the Ss sialoglycoprotein and its antigens in Rhnull erythrocytes.

Authors:  W Dahr; M Kordowicz; J Moulds; W Gielen; L Lebeck; J Krüger
Journal:  Blut       Date:  1987-01

2.  Site of attachment of encephalomyocarditis virus on human erythrocytes.

Authors:  G P Allaway; A T Burness
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

3.  A novel variety of the Dantu gene complex (DantuMD) detected in a Caucasian.

Authors:  W Dahr; P M Pilkington; H Reinke; D Blanchard; K Beyreuther
Journal:  Blut       Date:  1989-05

4.  The Dantu erythrocyte phenotype of the NE variety. II. Serology, immunochemistry, genetics, and frequency.

Authors:  P Unger; J L Procter; J J Moulds; M Moulds; D Blanchard; M L Guizzo; L A McCall; J P Cartron; W Dahr
Journal:  Blut       Date:  1987-07

5.  A family study of multiple mutations of alpha and delta glycophorins (glycophorins A and B).

Authors:  C H Huang; K V Puglia; W L Bigbee; M L Guizzo; M Hoffman; O O Blumenfeld
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

6.  Isolation of cDNA clones for human erythrocyte membrane sialoglycoproteins alpha and delta.

Authors:  C G Tate; M J Tanner
Journal:  Biochem J       Date:  1988-09-15       Impact factor: 3.857

7.  Pj variant, a new hybrid MNSs glycoprotein of the human red-cell membrane.

Authors:  D Blanchard; J P Cartron; P Rouger; C Salmon
Journal:  Biochem J       Date:  1982-05-01       Impact factor: 3.857

8.  Studies on Mv red cells. II. Immunochemical investigations.

Authors:  W Dahr; G Longster
Journal:  Blut       Date:  1984-10

9.  Multiple restriction fragment length polymorphisms associated with the Vc determinant of the MN blood group-related chimpanzee V-A-B-D system.

Authors:  A Rearden; H Phan; M Fukuda
Journal:  Biochem Genet       Date:  1990-04       Impact factor: 1.890

10.  Individuals lacking the Gerbich blood-group antigen have alterations in the human erythrocyte membrane sialoglycoproteins beta and gamma.

Authors:  D J Anstee; K Ridgwell; M J Tanner; G L Daniels; S F Parsons
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.